{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:19:42Z","timestamp":1763471982038,"version":"3.45.0"},"reference-count":33,"publisher":"Galenos Yayinevi","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"DOI":"10.4274\/tjps.galenos.2025.35559","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:49:31Z","timestamp":1763470171000},"page":"328-332","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacoeconomics Education in Pharmacy Faculties: Status in T\u00fcrkiye and Other Countries"],"prefix":"10.4274","volume":"22","author":[{"given":"Harun","family":"KIZILAY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1080\/00036846.2011.633895","article-title":"Ageing, chronic conditions and the evolution of future drugs expenditure: a five-year micro-simulation from 2004 to 2029","volume":"45","author":"Thi\u00e9baut","year":"2013","unstructured":"1. Thi\u00e9baut SP, Barnay T, Ventelou B. Ageing, chronic conditions and the evolution of future drugs expenditure: a five-year micro-simulation from 2004 to 2029. Appl Econ. 2013;45:1663-1672.","journal-title":"Appl Econ"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1186\/s12889-019-7762-5","article-title":"Consequences of chronic diseases and other limitations associated with old age - a scoping review","volume":"19","author":"Maresova","year":"2019","unstructured":"2. Maresova P, Javanmardi E, Barakovic S, Barakovic Husic J, Tomsone S, Krejcar O, Kuca K. Consequences of chronic diseases and other limitations associated with old age - a scoping review. BMC Public Health. 2019;19:1431.","journal-title":"BMC Public Health"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.med.0000433056.76699.5d","article-title":"Lifestyle medicine: the future of chronic disease management","volume":"20","author":"RF","year":"2013","unstructured":"3. Kushner RF, Sorensen KW. Lifestyle medicine: the future of chronic disease management. Curr Opin Endocrinol Diabetes Obes. 2013;20:389-395.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fpubh.2018.00328","article-title":"Barriers for access to new medicines: searching for the balance between rising costs and limited budgets","volume":"6","author":"Godman","year":"2018","unstructured":"4. Godman B, Bucsics A, Vella Bonanno P, Oortwijn W, Rothe CC, Ferrario A, Bosselli S, Hill A, Martin AP, Simoens S, Kurdi A, Gad M, Gulbinovi\u010d J, Timoney A, Bochenek T, Salem A, Hoxha I, Sauermann R, Massele A, Guerra AA Jr, Petrova G, Mitkova Z, Achniotou G, Laius O, Sermet C, Selke G, Kourafalos V, Yfantopoulos J, Magnusson E, Joppi R, Oluka M, Kwon HY, Jakupi A, Kalemeera F, Fadare JO, Melien O, Pomorski M, Wladysiuk M, Markovi\u0107-Pekovi\u0107 V, Mardare I, Meshkov D, Novakovic T, F\u00fcrst J, Tomek D, Zara C, Diogene E, Meyer JC, Malmstr\u00f6m R, Wettermark B, Matsebula Z, Campbell S, Haycox A. Barriers for access to new medicines: searching for the balance between rising costs and limited budgets. Front Public Health. 2018;6:328.","journal-title":"Front Public Health"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Querin G, Colella M. Gene therapy for primary myopathies: literature review and prospects. Arch Pediatr. 2023;30:8S18-8S23.","DOI":"10.1016\/S0929-693X(23)00223-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Gusmano MK, Okma KGH. Population aging and the sustainability of the welfare state. Hastings Cent Rep. 2018;48(S3):S57-S61.","DOI":"10.1002\/hast.915"},{"key":"ref6","unstructured":"7. Mikulic M. Global spending on medicines 2010-2027. Accessed June 30, 2024. https:\/\/www.statista.com\/statistics\/280572\/medicine-spending-worldwide"},{"key":"ref7","unstructured":"8. Belloni A, Morgan D, Paris V. Pharmaceut Exp Policy. 2016."},{"key":"ref8","unstructured":"9. OECD. Fiscal sustainability of health systems: how to finance more resilient health systems when money is tight? OECD Publ. 2024."},{"key":"ref9","unstructured":"10. McGhan M. Introduction to pharmacoeconomics. In: Pharmacoeconomics: From Theory to Practice. 2nd ed. CRC Press; 2021:243."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Rai M, Goyal R. Pharmacoeconomics in healthcare. In: Vohora D, Singh G, eds. Pharmaceut Med Transl Clin Res. Academic Press; 2018:465-472.","DOI":"10.1016\/B978-0-12-802103-3.00034-1"},{"key":"ref11","unstructured":"12. Hasamnis AA, Patil SS, Shaik I, K. N. A review of pharmacoeconomics: the key to \"healthcare for all.\" Syst Rev Pharm. 2019;10:40-42."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Thomas D, Sundararaj KGS, Shirwaikar A, Tarn YH. Inclusion of pharmacoeconomics course in the undergraduate pharmacy education: a global trend review. Indian J Pharm Pract. 2016;9.","DOI":"10.5530\/ijopp.9.3.3"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.46542\/pe.2021.211.276282","article-title":"Impact of using debates in a pharmacoeconomic course on students' self-reported perceptions of skills acquired","volume":"21","author":"Alaqeel","year":"2021","unstructured":"14. Alaqeel S, Alghamdi A, Balkhi B, Almazrou S, Alaujan S. Impact of using debates in a pharmacoeconomic course on students' self-reported perceptions of skills acquired. Pharm Educ. 2021;21:276-282.","journal-title":"Pharm Educ"},{"key":"ref14","unstructured":"15. Y\u00d6K. Our universities. Council High Educ. Accessed July 11, 2024. https:\/\/www.yok.gov.tr\/universiteler\/universitelerimiz"},{"key":"ref15","unstructured":"16. Y\u00d6K. Y\u00d6K Undergraduate Atlas. Council High Educ. Accessed July 11, 2024. https:\/\/yokatlas.yok.gov.tr\/lisans-bolum.php?b=10050"},{"key":"ref16","unstructured":"17. T\u00dc\u0130K. Health expenditure statistics, 2022. Turk Stat Inst. Accessed July 7, 2024. https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Saglik-Harcamalari-Istatistikleri-2022-49676"},{"key":"ref17","unstructured":"18. SGK. Social Security Institution medication reimbursement regulation. Off Gaz. 2022."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/iprp.s108047","article-title":"Role of the pharmacist in reducing healthcare costs: current insights","volume":"6","author":"Dalton","year":"2017","unstructured":"19. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37-46.","journal-title":"Integr Pharm Res Pract"},{"key":"ref19","unstructured":"20. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Univ Press; 2015."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Javor E, Allouch A, Osvaldi\u0107 Galic J, Skelin M. The economic impact of a clinical pharmacist's involvement in the hospital medicines policy in a rural area. Int J Clin Pract. 2021;75:e14859.","DOI":"10.1111\/ijcp.14859"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5688\/ajpe777145","article-title":"Pharmacoeconomics education in US colleges and schools of pharmacy","volume":"77","author":"Makhinova","year":"2013","unstructured":"22. Makhinova T, Rascati K. Pharmacoeconomics education in US colleges and schools of pharmacy. Am J Pharm Educ. 2013;77:145.","journal-title":"Am J Pharm Educ"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.3390\/healthcare11222923","article-title":"The state of pharmacoeconomics education in the Doctor of Pharmacy curriculum amid the changing face of pharmacy practice","volume":"11","author":"Adunlin","year":"2023","unstructured":"23. Adunlin G, Skiera J, Cupp CS, Ali AA, Afeli SAY. The state of pharmacoeconomics education in the Doctor of Pharmacy curriculum amid the changing face of pharmacy practice. Healthcare (Basel). 2023;11:2923.","journal-title":"Healthcare (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.vhri.2021.05.006","article-title":"Pharmacoeconomics education in the Middle East and North Africa region: a web-based research project","volume":"25","author":"Farid","year":"2021","unstructured":"24. Farid S, Baines D. Pharmacoeconomics education in the Middle East and North Africa region: a web-based research project. Value Health Reg Issues. 2021;25:182-188.","journal-title":"Value Health Reg Issues"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5455\/msm.2013.25.282-285","article-title":"Pharmacoeconomic education for pharmacy students in Bosnia and Herzegovina","volume":"25","author":"Catic","year":"2013","unstructured":"25. Catic T, Skrbo S. Pharmacoeconomic education for pharmacy students in Bosnia and Herzegovina. Mater Sociomed. 2013;25:282-285.","journal-title":"Mater Sociomed"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Freitas G, Balbinotto G. Pharmacoeconomic education in Brazilian schools of pharmacy. Value Health. 2014;17:A28.","DOI":"10.1016\/j.jval.2014.03.174"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5688\/ajpe77357","article-title":"Pharmacoeconomic education in Egyptian schools of pharmacy","volume":"77","author":"Soliman","year":"2013","unstructured":"27. Soliman AM, Hussein M, Abdulhalim AM. Pharmacoeconomic education in Egyptian schools of pharmacy. Am J Pharm Educ. 2013;77:57.","journal-title":"Am J Pharm Educ"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12991\/201414120","article-title":"Eczac\u0131l\u0131k fak\u00fcltelerinde farmakoekonomi e\u011fitimi ve \u00f6\u011frencilerin farmakoekonomi ile ilgili bilgi d\u00fczeyleri","volume":"18","author":"\u015eencan","year":"2014","unstructured":"28. \u015eencan N, Kurt M, Kaspar \u00c7, Wertheimer A. Eczac\u0131l\u0131k fak\u00fcltelerinde farmakoekonomi e\u011fitimi ve \u00f6\u011frencilerin farmakoekonomi ile ilgili bilgi d\u00fczeyleri. Marmara Pharm J. 2014;18:5-12.","journal-title":"Marmara Pharm J"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s41669-020-00250-7","article-title":"National healthcare economic evaluation guidelines: a cross-country comparison","volume":"5","author":"Sharma","year":"2021","unstructured":"29. Sharma D, Aggarwal AK, Downey LE, Prinja S. National healthcare economic evaluation guidelines: a cross-country comparison. Pharmacoeconomics Open. 2021;5:349-364.","journal-title":"Pharmacoeconomics Open"},{"key":"ref29","unstructured":"30. Rascati KL. Essentials of Pharmacoeconomics. 2nd ed. Baltimore, MD: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2009. p.155-162."},{"key":"ref30","unstructured":"31. Accreditation Council for Pharmacy Education (ACPE). Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy (Standards 2025). Chicago, IL; 2025. Available from: https:\/\/www.acpe-accredit.org\/pdf\/ACPEStandards2025.pdf"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Adunlin G, Skiera J, Cupp C. Assessment of the PharmD pharmacoeconomics educational environment in the United States. Value Health. 2023;26:S1764.","DOI":"10.1016\/j.jval.2023.03.1764"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5688\/ajpe777145","article-title":"Pharmacoeconomics education in US colleges and schools of pharmacy","volume":"77","author":"Makhinova","year":"2013","unstructured":"33. Makhinova T, Rascati K. Pharmacoeconomics education in US colleges and schools of pharmacy. Am J Pharm Educ. 2013;77:145.","journal-title":"Am J Pharm Educ"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:17:14Z","timestamp":1763471834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.turkjps.org\/articles\/pharmacoeconomics-education-in-pharmacy-faculties-status-in-turkiye-and-other-countries\/doi\/tjps.galenos.2025.35559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,11,18]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2025.35559","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"type":"print","value":"1304-530X"},{"type":"electronic","value":"2148-6247"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}